These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17914911)

  • 21. New drug targets for HIV and hepatitis C virus coinfection.
    Tedaldi EM
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S101-4. PubMed ID: 16265606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapy.
    Reiberger T; Kosi L; Maresch J; Breitenecker F; Payer BA; Wrba F; Rieger A; Gangl A; Peck-Radosavljevic M
    J Infect Dis; 2010 Jul; 202(1):156-60. PubMed ID: 20486858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection.
    Lafeuillade A; Hittinger G; Chadapaud S
    Lancet; 2001 Jan; 357(9252):280-1. PubMed ID: 11214134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic interventions for HIV infection and chronic viral hepatitis.
    Cooper CL
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-HCV Co-infection therapeutic outcomes have not improved over time.
    Cooper C; Costiniuk C; Giguère P
    HIV Clin Trials; 2009; 10(3):203-6. PubMed ID: 19632960
    [No Abstract]   [Full Text] [Related]  

  • 26. [Selection for treatment of hepatitis C co-infected patients for ].
    Findor J; Bessone F; Corti M
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S48-50; discussion S74-82. PubMed ID: 16862860
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of hepatitis C virus/HIV coinfection.
    Chun S; Sherman KE
    Clin Liver Dis; 2005 Aug; 9(3):525-33, ix. PubMed ID: 16023981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis C in the HIV-infected person].
    Teruya K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):682-7. PubMed ID: 15359885
    [No Abstract]   [Full Text] [Related]  

  • 29. Viral hepatitis and HIV: update and management.
    Núñez M; Mendes-Correa MC
    Antivir Ther; 2013; 18(3 Pt B):451-8. PubMed ID: 23792670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Human immunodeficiency virus infection and viral hepatitis].
    Soriano V; Martin-Carbonero L; Vispo E; Labarga P; Barreiro P
    Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):691-701. PubMed ID: 21978797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is hepatitis virus resistance to antiviral drugs a threat?
    Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1369-72. PubMed ID: 22537445
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV and hepatitis C coinfection.
    Matthews GV; Rockstroh J
    Curr Opin HIV AIDS; 2011 Nov; 6(6):449-50. PubMed ID: 22001889
    [No Abstract]   [Full Text] [Related]  

  • 33. OPERA: use of pegylated interferon plus ribavirin for treating HCV-HIV coinfection in interferon-naive patients.
    Carosi G; Bruno R; Cariti G; Nasta P; Gulminetti R; Galli M; Angarano G; Verucchi G; Pontali E; Capetti A; Raise E; Ravasio V; Maida I; Iannacone C; Caputo A; Puoti M
    Antivir Ther; 2014; 19(8):735-45. PubMed ID: 24583976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity.
    Audsley J; Bent SJ; Littlejohn M; Avihingsanon A; Matthews G; Bowden S; Bayliss J; Luciani F; Yuen L; Fairley CK; Locarnini S; Lewin SR; Sasadeusz J
    AIDS; 2016 Jun; 30(10):1597-606. PubMed ID: 26950313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of HIV and hepatitis virus coinfection.
    Mendes-Corrêa M; Núñez M
    Expert Opin Pharmacother; 2010 Oct; 11(15):2497-516. PubMed ID: 20629586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients.
    de Castro IF; Micheloud D; Berenguer J; Guzmán-Fulgencio M; Catalán P; Miralles P; Alvarez E; López JC; Cosín J; Lorente R; Muñoz-Fernández MA; Resino S
    AIDS; 2010 Aug; 24(13):2059-67. PubMed ID: 20616694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C management in HIV infection--where is the controversy?
    Dieterich DT
    AIDS Read; 2002 Jan; 12(1):22-3. PubMed ID: 11862657
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management.
    Jones M; Núñez M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):546-52. PubMed ID: 22001896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HIV infections].
    Teruya K
    Nihon Naika Gakkai Zasshi; 2004 Nov; 93(11):2357-62. PubMed ID: 15624472
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of insulin resistance in HIV/hepatitis C virus-coinfected patients.
    Eslam M; López-Cortés LF; Romero-Gomez M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):553-8. PubMed ID: 21934619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.